134 related articles for article (PubMed ID: 12409643)
1. Medulloblastomas with favorable versus unfavorable histology: how many small blue cell tumor types are there in the brain?
Perry A
Adv Anat Pathol; 2002 Nov; 9(6):345-50. PubMed ID: 12409643
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.
Eberhart CG; Kepner JL; Goldthwaite PT; Kun LE; Duffner PK; Friedman HS; Strother DR; Burger PC
Cancer; 2002 Jan; 94(2):552-60. PubMed ID: 11900240
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic grading of adult medulloblastomas.
Rodriguez FJ; Eberhart C; O'Neill BP; Slezak J; Burger PC; Goldthwaite P; Wu W; Giannini C
Cancer; 2007 Jun; 109(12):2557-65. PubMed ID: 17487854
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study.
Ozer E; Sarialioglu F; Cetingoz R; Yüceer N; Cakmakci H; Ozkal S; Olgun N; Uysal K; Corapcioglu F; Canda S
Pathol Res Pract; 2004; 200(7-8):501-9. PubMed ID: 15462497
[TBL] [Abstract][Full Text] [Related]
5. Stratification of medulloblastoma on the basis of histopathological grading.
Giangaspero F; Wellek S; Masuoka J; Gessi M; Kleihues P; Ohgaki H
Acta Neuropathol; 2006 Jul; 112(1):5-12. PubMed ID: 16685513
[TBL] [Abstract][Full Text] [Related]
6. Anaplasia is rare and does not influence prognosis in adult medulloblastoma.
Giordana MT; D'Agostino C; Pollo B; Silvani A; Ferracini R; Paiolo A; Ghiglione P; Chiò A
J Neuropathol Exp Neurol; 2005 Oct; 64(10):869-74. PubMed ID: 16215458
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
Min HS; Lee YJ; Park K; Cho BK; Park SH
Acta Neuropathol; 2006 Jul; 112(1):13-20. PubMed ID: 16691420
[TBL] [Abstract][Full Text] [Related]
8. Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.
Triscott J; Yip S; Johnston D; Michaud J; Rassekh SR; Hukin J; Dunn S; Dunham C
Pediatr Dev Pathol; 2021; 24(4):309-317. PubMed ID: 33749384
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic grading of medulloblastomas.
Ho DM; Hsu CY; Chiang H
Cancer; 2002 Dec; 95(12):2577-8; author reply 2578-9. PubMed ID: 12467073
[No Abstract] [Full Text] [Related]
10. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
11. Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.
McManamy CS; Lamont JM; Taylor RE; Cole M; Pearson AD; Clifford SC; Ellison DW;
J Neuropathol Exp Neurol; 2003 Jun; 62(6):627-32. PubMed ID: 12834107
[TBL] [Abstract][Full Text] [Related]
12. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
13. "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.
Brown HG; Kepner JL; Perlman EJ; Friedman HS; Strother DR; Duffner PK; Kun LE; Goldthwaite PT; Burger PC
J Neuropathol Exp Neurol; 2000 Oct; 59(10):857-65. PubMed ID: 11079775
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.
Son EI; Kim IM; Kim DW; Yim MB; Kang YN; Lee SS; Kwon KY; Suh SI; Kwon TK; Lee JJ; Kim DS; Kim SP
Pathol Int; 2003 Feb; 53(2):67-73. PubMed ID: 12588433
[TBL] [Abstract][Full Text] [Related]
15. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
Ellison DW; Onilude OE; Lindsey JC; Lusher ME; Weston CL; Taylor RE; Pearson AD; Clifford SC;
J Clin Oncol; 2005 Nov; 23(31):7951-7. PubMed ID: 16258095
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma variants and survival at a children's hospital.
Craver R; Sandquist D; Nadell J; Velez M
Fetal Pediatr Pathol; 2011; 30(1):53-9. PubMed ID: 21204667
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
Korshunov A; Sahm F; Okonechnikov K; Ryzhova M; Stichel D; Schrimpf D; Casalini B; Sievers P; Meyer J; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; Kool M; von Deimling A
Acta Neuropathol; 2019 Jun; 137(6):1003-1015. PubMed ID: 30826918
[TBL] [Abstract][Full Text] [Related]
18. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
[TBL] [Abstract][Full Text] [Related]
19. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
Bien-Willner GA; López-Terrada D; Bhattacharjee MB; Patel KU; Stankiewicz P; Lupski JR; Pfeifer JD; Perry A
Neuro Oncol; 2012 Jul; 14(7):831-40. PubMed ID: 22573308
[TBL] [Abstract][Full Text] [Related]
20. Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus.
Eberhart CG; Chaudhry A; Daniel RW; Khaki L; Shah KV; Gravitt PE
BMC Cancer; 2005 Feb; 5():19. PubMed ID: 15717928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
